seed
Stage
1
Investors
About
Procarta Biosystems develops novel oligonucleotide-based antimicrobial agents targeting serious infections and antimicrobial resistance by creating medicines active against resistant bacterial strains with controllable microbiological spectra.
Explore Procarta Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.